Palantir (PLTR) Stock Tumbles 5% Amid Political Scrutiny Over Government Contracts Worth $2.2B

Key Takeaways

• Shares of Palantir closed approximately 4.8% lower at $127.88 on Wednesday, halting a seven-session rally that had driven the stock up 25%.
• Concerns emerged following a Financial Times article discussing potential political opposition to Palantir’s government work from Democratic legislators.
• Federal contract revenues reached approximately $2.2 billion in the twelve months since Trump’s presidential return, marking a 65% annual increase.
• The stock continues to trade beneath both its 100-day and 200-day moving averages, maintaining a Death Cross pattern established in February.
• Wall Street maintains a Buy consensus rating with a $174.10 average price target; the company’s next earnings release is projected for August 3.

Palantir Technologies (PLTR) experienced a significant decline Wednesday, ending a seven-session upward momentum. Shares retreated approximately 4.8% to close at $127.88, positioning the data analytics firm among the S&P 500’s weakest performers for the trading day.

Palantir Technologies Inc., PLTR

The downturn followed publication of a Financial Times piece highlighting internal company discussions and suggesting Democratic legislators might leverage subpoena authority to investigate Palantir’s federal government engagements should they reclaim House majority control.

DA Davidson’s Gil Luria spoke with Barron’s, attributing the price movement directly to the Financial Times coverage. Luria contested the political risk thesis, emphasizing that Palantir has maintained Defense Department relationships through five different administrations spanning both major political parties.

“Each successive administration has expanded its reliance on Palantir’s capabilities beyond what came before,” Luria noted.

The timing carries significance. PLTR had concluded Tuesday’s session precisely at its 50-day moving average near $134. Wednesday’s reversal indicates the stock encountered resistance at that technical threshold before retreating.

Palantir declined to provide commentary when contacted.

Congressional Concerns and Federal Revenue Exposure

While political controversy surrounding Palantir isn’t unprecedented, the Financial Times piece elevated these concerns prominently. The company has faced ongoing criticism regarding its contracts with U.S. immigration authorities, defense entities, and involvement in Israel’s Gaza operations.

The heightened attention carries weight given the financial stakes involved. Federal contract revenues approached $2.2 billion during the twelve-month period following Trump’s presidential inauguration—representing a 65% year-over-year surge. Meanwhile, commercial segment revenues more than doubled during this timeframe.

Any material interruption to these government agreements would represent substantive business impact beyond mere reputational considerations.

Notably, investor Michael Burry has established a short position against PLTR, contending that Anthropic represents competitive pressure in the artificial intelligence domain. Chief Executive Alex Karp has countered this perspective, asserting that large-scale AI models generate challenges that Palantir’s solutions are specifically designed to address for enterprise clients.

Technical Analysis of PLTR

The broader technical landscape remains challenging. PLTR currently trades 18.6% beneath its 200-day moving average of $157.31 and 7.9% under its 100-day moving average at $139.05. The Death Cross pattern—where the 50-day average crosses below the 200-day average—materialized in February and persists.

Year-to-date in 2026, Palantir shares have declined 29% and remain 39% off the all-time closing peak of $207.18 reached November 3, 2025.

The recent seven-day advance provided temporary respite. Following a June 25 trough at $107.27, PLTR rallied 25% across seven consecutive sessions. This momentum stemmed partially from an announced collaboration with Nvidia focused on developing specialized AI architectures for federal government applications, complemented by DA Davidson’s rating upgrade to Buy with a $175 price objective.

Wednesday’s retreat disrupted this positive trajectory.

Investors now turn attention toward the company’s upcoming earnings announcement, anticipated for August 3. Analyst projections call for earnings per share of 33 cents, double the 16 cents reported in the year-ago quarter, alongside revenue expectations of $1.81 billion versus $1.00 billion previously.

Wall Street maintains a consensus Buy recommendation on the shares with an average twelve-month price target of $174.10.